133 related articles for article (PubMed ID: 21079232)
21. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
Zufferey PJ; Samama CM; Rosencher N
Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
[No Abstract] [Full Text] [Related]
22. Prolonged thromboprophylaxis with enoxaparin in early neurological rehabilitation.
Lang A; Kienitz C; Wetzel P; Rollnik JD
Clin Appl Thromb Hemost; 2011 Oct; 17(5):470-5. PubMed ID: 20547551
[TBL] [Abstract][Full Text] [Related]
23. Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study.
Hacobian M; Shetty R; Niles CM; Gerhard-Herman M; Vallurupalli N; Baroletti S; McKean SC; Sonis J; Parasuraman S; Kosowsky JM; Goldhaber SZ
Clin Appl Thromb Hemost; 2010 Feb; 16(1):21-5. PubMed ID: 19147527
[TBL] [Abstract][Full Text] [Related]
24. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
25. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
J Med Econ; 2011; 14(6):824-34. PubMed ID: 22023098
[TBL] [Abstract][Full Text] [Related]
26. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
Caprini JA
Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
[No Abstract] [Full Text] [Related]
28. The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy.
Krafft A
Thromb Haemost; 2007 Dec; 98(6):1155-6. PubMed ID: 18064306
[No Abstract] [Full Text] [Related]
29. [Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?].
Pelzer U; Sinn M; Stieler J; Riess H
Dtsch Med Wochenschr; 2013 Oct; 138(41):2084-8. PubMed ID: 24085361
[TBL] [Abstract][Full Text] [Related]
30. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin.
Spinal Cord Injury Thromboprophylaxis Investigators
J Trauma; 2003 Jun; 54(6):1111-5. PubMed ID: 12813331
[TBL] [Abstract][Full Text] [Related]
31. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Huisman MV; Quinlan DJ; Dahl OE; Schulman S
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
33. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
DeCarolis DD
N Engl J Med; 2006 Jun; 354(26):2830; author reply 2831-2. PubMed ID: 16807424
[No Abstract] [Full Text] [Related]
34. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
Marlovits S; Striessnig G; Schuster R; Stocker R; Luxl M; Trattnig S; Vécsei V
Arthroscopy; 2007 Jul; 23(7):696-702. PubMed ID: 17637403
[TBL] [Abstract][Full Text] [Related]
35. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin.
Spinal Cord Injury Thromboprophylaxis Investigators
J Trauma; 2003 Jun; 54(6):1116-24; discussion 1125-6. PubMed ID: 12813332
[TBL] [Abstract][Full Text] [Related]
36. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
Bergqvist D; Agnelli G; Cohen AT; Eldor A; Nilsson PE; Le Moigne-Amrani A; Dietrich-Neto F;
N Engl J Med; 2002 Mar; 346(13):975-80. PubMed ID: 11919306
[TBL] [Abstract][Full Text] [Related]
37. Invited commentary.
Henke PK
J Vasc Surg; 2010 Nov; 52(5):1270-1. PubMed ID: 21050988
[No Abstract] [Full Text] [Related]
38. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
[TBL] [Abstract][Full Text] [Related]
39. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
[TBL] [Abstract][Full Text] [Related]
40. Review of a large clinical series: once- versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients.
Bush S; LeClaire A; Hampp C; Lottenberg L
J Intensive Care Med; 2011; 26(2):111-5. PubMed ID: 21257630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
